Cited by 98Cardiac Fibrosis and RemodelingCardiac Ischemia and ReperfusionThyroid Disorders and Treatments

Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodelling in rats

Open access
Forini, Francesca, Lionetti, Vincenzo, Ardehali, Hossein, Pucci, Angela, Cecchetti, Federica, Ghanefar, Mohsen, Nicolini, Giuseppina, Ichikawa, Yoshihiko +3 more·2011·Journal of Cellular and Molecular Medicine

Abstract

3,5,3'-Levo-triiodothyronine (L-T3) is essential for DNA transcription, mitochondrial biogenesis and respiration, but its circulating levels rapidly decrease after myocardial infarction (MI). The main aim of our study was to test whether an early and sustained normalization of L-T3 serum levels after MI exerts myocardial protective effects through a mitochondrial preservation. Seventy-two hours after MI induced by anterior interventricular artery ligation, rats were infused with synthetic L-T3 (1.2 μg/kg/day) or saline over 4 weeks. Compared to saline, L-T3 infusion restored FT3 serum levels at euthyroid state (3.0 ± 0.2 versus 4.2 ± 0.3 pg/ml), improved left ventricular (LV) ejection fraction (39.5 ± 2.5 versus 65.5 ± 6.9%), preserved LV end-systolic wall thickening in the peri-infarct zone (6.34 ± 3.1 versus 33.7 ± 6.21%) and reduced LV infarct-scar size by approximately 50% (all P < 0.05). Moreover, L-T3 significantly increased angiogenesis and cell survival and enhanced the expression of nuclear-encoded transcription factors involved in these processes. Finally, L-T3 significantly increased the expression of factors involved in mitochondrial DNA transcription and biogenesis, such as hypoxic inducible factor-1α, mitochondrial transcription factor A and peroxisome proliferator activated receptor γ coactivator-1α, in the LV peri-infarct zone. To further explore mechanisms of L-T3 protective effects, we exposed isolated neonatal cardiomyocytes to H(2)O(2) and found that L-T3 rescued mitochondrial biogenesis and function and protected against cell death via a mitoKATP dependent pathway. Early and sustained physiological restoration of circulating L-T3 levels after MI halves infarct scar size and prevents the progression towards heart failure. This beneficial effect is likely due to enhanced capillary formation and mitochondrial protection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1582-4934.2010.01014.x

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • T3 mitochondrial protection is also exerted through the mitochondrial ATP-dependent potassium pathway, peroxisome proliferator-activated receptor gamma coactivator 1-alpha, and mitochondrial transcription factor A.

    “T 3 mitochondrial protection is also exerted through other pathways, including mitochondrial adenosine triphosphatedependent potassium pathway, peroxisome proliferator-activated receptor gamma coactivator 1-alpha, and the mitochondrial transcription factor A (25).”

    From Thyroid Hormones and Cardiovascular Function and Diseases (2018) · cites this paper as [25]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Forini, F., Lionetti, V., Ardehali, H., Pucci, A., Cecchetti, F., Ghanefar, M., Nicolini, G., Ichikawa, Y., Nannipieri, M., Recchia, F. A., & Iervasi, G.
Affiliations
  • Istituto di Fisiologia Clinica (IT)
  • Scuola Superiore Sant'Anna (IT)
  • Northwestern University (US)
  • Azienda Ospedaliera Universitaria Pisana (IT)
  • University of Pisa (IT)
Corresponding author
Iervasi, Giorgio
Venue
Journal of Cellular and Molecular Medicine
Publisher
Wiley
Published
2010-01-20
Volume
15
Issue
3
Pages
514-524
ISSN
1582-1838 (ISSN-L)
OpenAlex
W2013644808
Cited by
98
References
54
Citations by year
2026: 3 · 2025: 7 · 2024: 5 · 2023: 4 · 2022: 5 · 2021: 3 · 2020: 8 · 2019: 7 · 2018: 6 · 2017: 5 · 2016: 12 · 2015: 8 · 2014: 6 · 2013: 6 · 2012: 4
FWCI
4.17
Type
journal article
Language
en
Open access
Locations
  • Journal of Cellular and Molecular Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutional Research Information System (Sant'Anna School of Advanced Studies) (submittedVersion)
Funders
National Heart, Lung, and Blood Institute (R01HL108213, R01HL087149, K08HL079387)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Cardiac Ischemia and Reperfusion
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
Keywords
levothyroxine, triiodothyronine, myocardial infarction, mitochondrial biogenesis, mitochondrial transcription, hypoxia-inducible factor-1α, TFAM, PGC-1α, angiogenesis, cardiomyocyte survival, hydrogen peroxide-induced cell death, mitoKATP channel, heart failure prevention, left ventricular ejection fraction
MeSH terms
Animals, Capillaries, Cells, Cultured, Hemodynamics, Hydrogen Peroxide, Male, Mitochondria, Myocardial Infarction, Random Allocation, Thyroxine, Time Factors, Triiodothyronine, Blotting, Western, Oxidants, Rats, Wistar, Apoptosis, Reverse Transcriptase Polymerase Chain Reaction, Hormone Replacement Therapy, Ventricular Remodeling, Myocytes, Cardiac, Rats, Hypoxia-Inducible Factor 1, alpha Subunit, Infusions, Subcutaneous

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review